{
    "id": "475",
    "title": "Khorana Risk Score for Venous Thromboembolism in Cancer Patients",
    "desc": "The Khorana Risk Score for VTE predicts risk of VTE for cancer patients depending on type of cancer and other factors.",
    "data": {
        "orgreference": [
            {
                "href": "https://www.bloodjournal.org/content/bloodjournal/111/10/4902.full.pdf?sso-checked=true",
                "text": "Khorana AA, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111:4902-7."
            }
        ],
        "other_refer": [
            {
                "href": "https://www.ncbi.nlm.nih.gov/pubmed/25873061",
                "text": "Lyman GH, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jun 10;31(17):2189-204. doi: 10.1200/JCO.2013.49.1118. Epub 2013 May 13."
            },
            {
                "href": "https://www.nejm.org/doi/full/10.1056/NEJMoa1814630",
                "text": "Khorana AA, Soff GA, Kakkar AK, et al. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. N Engl J Med. 2019;380(8):720-728."
            },
            {
                "href": "https://www.nejm.org/doi/full/10.1056/NEJMoa1814468",
                "text": "Carrier M, Abou-nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019;380(8):711-719."
            }
        ],
        "evidence": "<p>Addition of selected points.</p>",
        "facts": "<p><strong>Score interpretation</strong></p>\n<div class=\"table-responsive\">\n<table class=\"table table-bordered table-hover\">\n<tbody>\n<tr>\n<th>Risk Group</th>\n<th>Score</th>\n<th>2.5-month rate of VTE</th>\n</tr>\n<tr>\n<td>Low</td>\n<td>0</td>\n<td>0.3-0.8%</td>\n</tr>\n<tr>\n<td>Intermediate</td>\n<td>1 - 2</td>\n<td>1.8-2.0%</td>\n</tr>\n<tr>\n<td>High</td>\n<td>&ge;3</td>\n<td>6.7-7.1%</td>\n</tr>\n</tbody>\n</table>\n</div>",
        "estimation": [],
        "primary_complains": [
            "Shortness of Breath",
            "Weakness"
        ],
        "disease_treated": [
            "Cancer",
            "Chemotherapy",
            "Deep Venous Thrombosis",
            "Pulmonary Embolism"
        ],
        "logic": "var calc_output = [];\n\nvar ca = parseInt(ca);\nvar plt = parseInt(plt);\nvar hb = parseInt(hb);\nvar leuk = parseInt(leuk);\nvar bmi = parseInt(bmi);\nvar u = ca + plt + hb + leuk + bmi;\nvar msg;\n\nif (u == 0) { mini_msg = 'Low Risk';\n    msg = 'Low Risk (0 Points)<br/><br/>Rate of VTE at 2.5 months* = 0.3 - 0.8%'; }\nif (u == 1 || u == 2) { mini_msg = 'Intermediate Risk';\n    msg = 'Intermediate Risk (1-2 Points)<br/><br/>Rate of VTE at 2.5 months* = 1.8 - 2.0%'; }\nif (u > 2) { mini_msg = 'High Risk';\n    msg = 'High Risk (≥3 Points)<br/><br/>Rate of VTE at 2.5 months* = 6.7 - 7.1%'; }\nmsg += \"<br/><br/>*Note: Median follow-up time was 2.5 months.\";\n\ncalc_output.push({\n    name: 'mini',\n    value: u.toFixed(0),\n    value_text: 'points',\n    message: mini_msg\n});\ncalc_output.push({\n    name: '3315_Khorana Risk Score_result',\n    value: u.toFixed(0),\n    value_text: 'points',\n    message: msg\n});",
        "inputs": [
            {
                "conditionality": "",
                "default": null,
                "label_en": "Cancer type",
                "name": "ca",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "Stomach",
                        "value": 2
                    },
                    {
                        "label": "Pancreas",
                        "value": 2
                    },
                    {
                        "label": "Lung",
                        "value": 1
                    },
                    {
                        "label": "Lymphoma",
                        "value": 1
                    },
                    {
                        "label": "Gynecologic",
                        "value": 1
                    },
                    {
                        "label": "Bladder",
                        "value": 1
                    },
                    {
                        "label": "Testicular",
                        "value": 1
                    },
                    {
                        "label": "Other",
                        "value": 0
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "radio"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "the number of white blood cells. ",
                "name": "plt",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "toggle"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "Hemoglobin level <10 g/dL or using RBC growth factors",
                "name": "hb",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "toggle"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "pre-chemotherapy leukocyte count greater than 11x10^9/L. ",
                "name": "leuk",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "toggle"
            },
            {
                "conditionality": "",
                "default": 0,
                "label_en": "BMI ≥35 kg/m². ",
                "name": "bmi",
                "option_fhir_rules": null,
                "optional": false,
                "options": [
                    {
                        "label": "No",
                        "value": 0
                    },
                    {
                        "label": "Yes",
                        "value": 1
                    }
                ],
                "show_points": true,
                "tips_en": "",
                "type": "toggle"
            }
        ],
        "can_search": [
            "Vte",
            "dvt",
            "cancer",
            "ca",
            "pe",
            "embolism",
            "thrombosis",
            "chemo"
        ],
        "specialty": [
            "Hematology and Oncology",
            "Hospitalist Medicine",
            "Internal Medicine",
            "Pulmonology",
            "Radiation Oncology"
        ]
    }
}